ADMA Biologics Inc.
ADMA | NASDAQ
$9.52
+$0.01 (+0.16%)
Sep 22, 2026, 9:48 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 168.96M | 165.35M | 146.93M | 209.45M | 208.93M | 206.77M | 197.67M | 68.13M | 34.79M | -3.64M | -28.24M | -22.83M | -40.29M | -47.69M | -65.9M | -70.32M | -73.14M | -78.28M | -71.65M | -74.41M | -73.61M | -74.88M |
Depreciation & Amortization | 7.69M | 7.97M | 8.1M | 7.99M | 7.91M | 8.13M | 8.27M | 8.44M | 9.31M | 9.13M | 9.05M | 8.88M | 7.93M | 7.56M | 7.11M | 6.69M | 6.25M | 5.86M | 5.5M | 5.21M | 4.82M | 4.38M |
Stock-Based Compensation | 22.9M | 21.73M | 20.03M | 20.07M | 18.2M | 16.1M | 13.62M | 9.93M | 8.44M | 7.22M | 6.19M | 5.51M | 5.13M | 4.68M | 5.21M | 5.36M | 4.73M | 4.35M | 3.49M | 2.96M | 3.05M | 2.96M |
Other Working Capital | 11.44M | 11.81M | 2.74M | 572K | -5.96M | -10.37M | -2.78M | -6.36M | -737.88K | 10.17M | 7.58M | 10.01M | 11.78M | 7.53M | 6.4M | 2.95M | 3.28M | 7.44M | 5.49M | 3.39M | 4.81M | 3.32M |
Other Non-Cash Items | -8.95M | -4.02M | 3.92M | -79.03M | -81.12M | -84.29M | -84.21M | 26.36M | 27.17M | 30.7M | 31.91M | 5.98M | 6.87M | 6.58M | 12.35M | 11.11M | 9.63M | 8.71M | 1.89M | 1.69M | 1.67M | 1.65M |
Deferred Income Tax | 9.27M | 10.89M | 11.02M | 9.85M | 5.05M | 3.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.34K | 79.7K | 80.48K | -842.1K | -835.48K | -910.3K |
Change in Working Capital | -63.15M | -73.6M | -139.6M | -103.35M | -82.26M | -48.91M | -16.68M | -26.8M | -6.71M | -22.11M | -10.11M | -13.72M | -21.08M | -19.35M | -18.29M | -38.44M | -33.21M | -45.87M | -51.68M | -45.74M | -56.66M | -43.79M |
Operating Cash Flow | 136.72M | 128.32M | 50.4M | 64.97M | 76.71M | 101.22M | 118.67M | 86.05M | 73.01M | 21.3M | 8.8M | -16.18M | -41.45M | -48.22M | -59.51M | -85.59M | -85.72M | -105.15M | -112.37M | -111.12M | -121.56M | -110.59M |
Capital Expenditures | -20.25M | -20.42M | -22.58M | -24.25M | -10.94M | -10.58M | -8.23M | -6.67M | -6.37M | -5.17M | -4.77M | -7.32M | -9.95M | -13.01M | -13.91M | -13.84M | -13.25M | -13.78M | -13.51M | -13.43M | -13.53M | -13.22M |
Cash Acquisitions | 1M | 6M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 4.76M | -297K | -316K | -117K | -117K | -311K | -307K | -314K | -314K | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -14.5M | -14.77M | -21.89M | -24.37M | -11.1M | -10.93M | -8.58M | -7.23M | -6.89M | -5.4M | -4.98M | -7.32M | -9.95M | -13.01M | -13.91M | -13.84M | -13.25M | -13.78M | -13.51M | -13.43M | -13.53M | -13.22M |
Debt Repayment | 121.34M | 121.36M | -3.17M | -33.72M | -60.45M | -60M | -60M | -68.66M | -38.66M | -38.67M | -38.68M | -25.87K | -35.12K | -37.74K | 51.71M | 51.71M | 51.71M | 51.72M | -34.3K | 1.02M | 1.02M | 1.02M |
Common Stock Repurchased | -187.19M | -162.13M | -39.17M | -30.91M | -7.87M | -8.57M | -3.81M | -3.17M | -3.38M | -2.21M | -376.45K | -376.45K | -598.44K | -1.38M | -831.3K | -831.3K | -401.32K | -91.37K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -12.08M | -9.72M | -4.56M | -3.75M | -3.01M | -1.11M | -180K | -138.45K | 1.64M | 1.09M | 58.58K | -1.49M | -2.52M | -2.3M | -6.68M | -4.78M | -4.38M | -4.38M | -61.6K | -891.6K | -889.31K | -883.06K |
Financial Cash Flow | -76.49M | -47.03M | -44.02M | -65.93M | -63.57M | -63.98M | -58.3M | -66.27M | -40.39M | -39.78M | -38.99M | 62.75M | 61.49M | 60.93M | 108.85M | 99.93M | 108.97M | 126.47M | 121.05M | 99.29M | 101.72M | 84.54M |
Net Cash Flow | 45.74M | 66.53M | -15.52M | -25.32M | 2.04M | 26.3M | 51.8M | 12.55M | 25.73M | -23.88M | -35.17M | 39.25M | 10.1M | -301.4K | 35.43M | 495.45K | 10.01M | 7.54M | -4.83M | -25.26M | -33.37M | -39.27M |
Free Cash Flow | 116.47M | 107.9M | 27.82M | 40.73M | 65.77M | 90.64M | 110.45M | 79.39M | 66.64M | 16.13M | 4.03M | -23.5M | -51.39M | -61.23M | -73.42M | -99.43M | -98.97M | -118.94M | -125.88M | -124.56M | -135.09M | -123.81M |
Adj. Free Cash Flow | 93.57M | 86.17M | 7.8M | 20.66M | 47.57M | 74.54M | 96.83M | 69.46M | 58.2M | 8.91M | -2.16M | -29.01M | -56.52M | -65.92M | -78.63M | -104.79M | -103.7M | -123.28M | -129.37M | -127.52M | -138.14M | -126.77M |
Maintenance CapEx | -14.11M | -12.33M | -10.49M | -10.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.51M | -1.51M | -4.35M |
Growth CapEx | -6.14M | -8.08M | -12.08M | -13.75M | -10.94M | -10.58M | -8.23M | -6.67M | -6.37M | -5.17M | -4.77M | -7.32M | -9.95M | -13.01M | -13.91M | -13.84M | -13.25M | -13.78M | -13.51M | -11.92M | -12.02M | -8.87M |
Owner Earnings | 122.61M | 115.99M | 39.9M | 54.48M | 76.71M | 101.22M | 118.67M | 86.05M | 73.01M | 21.3M | 8.8M | -16.18M | -41.45M | -48.22M | -59.51M | -85.59M | -85.72M | -105.15M | -112.37M | -112.64M | -123.08M | -114.94M |
Add to Watchlist
Select watchlists to add or remove ADMA